NCT03205462View on ClinicalTrials.gov

An Open Study to Assess the Safety and Pharmacokinetics of Fluorothyazinone as a Single-Dose Administration or a Treatment Course in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

December 8, 2017

Study Completion Date

December 15, 2017

Conditions
Healthy Volunteer
Interventions
DRUG

Fluorothyazinone 300 mg

Fluorothyazinone in a dosage of 300 mg (1 tablet)

DRUG

Fluorothyazinone 600 mg

Fluorothyazinone in a dosage of 600 mg (2 tablets) is received per os (oral administration) as a single dose

DRUG

Fluorothyazinone 3900 mg

The total dose of Fluorothyazinone per treatment course is 3900 mg.

Trial Locations (1)

123995

"Federal State Budget-Funded Educational Institution for Additional Professional Education Russian Medical Academy for Postgraduate Education of the Ministry of Health of the Russian Federation", Moscow

Sponsors
All Listed Sponsors
collaborator

Center of Pharmaceutical Analytics LLC

INDUSTRY

lead

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

OTHER

NCT03205462 - An Open Study to Assess the Safety and Pharmacokinetics of Fluorothyazinone as a Single-Dose Administration or a Treatment Course in Healthy Volunteers | Biotech Hunter | Biotech Hunter